Who Paid My Doc
Stephen Eppes
Pediatric Infectious Diseases Wilmington, DE Medical Doctor
NPI 1689765976 CMS profile 76729
A.I. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803
General payments
$40
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$6,500
Through program year 2025, Stephen Eppes of Wilmington, DE is reported in the CMS Open Payments database as having received $40 across 1 general payment and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $6,500 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 16th percentile of Pediatric Infectious Diseases profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $40 | 1 |
Beside peers
- Stephen Eppes
- Pediatric Infectious Diseases median
- Middle half of Pediatric Infectious Diseases
- National median
In program year 2025, general payments to Stephen Eppes were reported at $40. Among 311 Pediatric Infectious Diseases profiles paid that year, the median was $126 and the middle half received between $41 and $2,094.
Show as a table
| Year | Stephen Eppes | Pediatric Infectious Diseases median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $175 | $34–$2,175 | $163 |
| 2020 | $0 | $521 | $34–$6,009 | $114 |
| 2021 | $0 | $1,077 | $39–$4,557 | $132 |
| 2022 | $0 | $232 | $53–$6,196 | $149 |
| 2023 | $0 | $140 | $52–$4,662 | $160 |
| 2024 | $0 | $198 | $52–$3,860 | $164 |
| 2025 | $40 | $126 | $41–$2,094 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
212
Drug cost
$741,974
Branded share of claims
80.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | Brand | 116 | $499,114 | |
| Triumeq Abacavir/Dolutegravir/Lamivudi | Brand | 23 | $86,776 | |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | Brand | 18 | $71,736 | |
| Symtuza Darunavir/Cob/Emtri/Tenof Alaf | Brand | 14 | $66,055 | |
| Darunavir | Generic | 12 | $18,176 | |
| Alendronate Sodium | Generic | 16 | $73 | |
| Atorvastatin Calcium | Generic | 13 | $44 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,546 Part D prescribers listed as Infectious Disease; they describe a distribution and say nothing about conduct.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Pediatric Infectious Diseases in Delaware
Related records
Pediatric Infectious Diseases in Delaware
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Infectious Diseases
Everyone recorded under this specialty, nationwide.
Doctors in Delaware
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.